Breaking News Instant updates and real-time market news.

VRX

Valeant

07:03
06/08/16
06/08
07:03
06/08/16
07:03

Saying 'things can always get worse,' Wells cuts Valeant price target

Wells Fargo analyst David Maris lowered his estimates for Valeant Pharmaceuticals following the company's Q1 results and cut his price target range for the shares to $17-$22 from $25-$30. The embattled drugmaker closed yesterday down 14% to $24.67 after cutting its outlook for 2016. "Sometimes something is so complex and so persistently negative that people become fatigued by it," leading to stock buying on the belief that things can't get worse, Maris tells investors in a post-earnings research note. "Things can always get worse," he reminds investors. Maris believes this is the case for Valeant. "There was really nothing in the quarter that was a bright spot," he argues. Further, the analyst believes Valeant may face "significant challenges" to meet its debt obligations in 2020. He keeps an Underperform rating on the shares.

  • 10

    Jun

  • 14

    Jun

  • 19

    Jul

  • 16

    Nov

VRX Valeant

05/27/16
PIPR
05/27/16
NO CHANGE
PIPR
Underweight
Valeant takeover rejection report 'difficult to fathom,' says Piper Jaffray
Piper Jaffray analyst David Amsellem noted the report claiming that Valeant (VRX) previously rejected a takeover offer from Takeda (TKPYY) and TPG prior to appointing Joe Papa as CEO, but said he finds it "difficult to fathom" why a buyer would have interest in the entire asset portfolio, since he believes the value of its segments to be "meaningfully" below the company's $31B in total debt outstanding. Amsellem, who thinks there would be significant strategic interest in Valeant's gastroenterology assets, believes that any strategic activity will come in the form of asset sales or a breakup of the company. The firm keeps an Underweight rating on Valeant shares.
06/03/16
ADAM
06/03/16
NO CHANGE
Target $40
ADAM
Hold
Valeant challenges remain and work to be done, says Canaccord
Canaccord analyst Neil Maruoka previewed Q1 results for Valeant (VRX) scheduled for June 7th. The analyst expects many of the issues from last year to spill into the first quarter including lost sales from Philidor, potential challenges with the implementation of the Walgreens (WBA) distribution agreement, and pricing headwinds. Maruoka remains cautious ahead of likely Q1 results and the potential for lowered guidance and so maintains his Hold rating and $40 price target on Valeant shares.
06/07/16
WELS
06/07/16
NO CHANGE
WELS
Underperform
Valeant performing 'significantly worse than expected,' says Wells Fargo
Wells Fargo analyst David Maris says his preliminary look at Valeant's Q1 results indicate the company is performing "significantly worse than expected." Despite the SEC's correspondence with Valeant over the past several months over not prominently focusing on adjusted non-GAAP measures, Valeant only provided non-GAAP earnings guidance, Maris tells investors in a post-earnings research note. "We are uncertain as to why Valeant continues not to provide GAAP earnings forecasts for investors," Maris writes. He believes the company will be challenged to make its debt payments through 2020 if the business stays the way it is. The Walgreens (WBA) program "seems uninspiring," Maris adds. The analyst keeps an Underperform rating on Valeant with a $25-$30 price target range. The stock is down 16%, or $4.58, to $24.26 in pre-market trading with the company's earnings conference call ongoing.
06/08/16
JPMS
06/08/16
NO CHANGE
Target $50
JPMS
Overweight
Valeant price target lowered to $50 from $60 at JPMorgan
JPMorgan analyst Chris Schott lowered his price target for Valeant Pharmaceuticals to $50 from $60 following the drugmaker's Q1 results. The stock closed yesterday down 14%, or $4.18, to $24.67. After meeting with management following yesterday's results, Schott views Valeant's reduced guidance as achievable and is encouraged by the steps new CEO Joe Papa is taking to stabilize the business. He expects, however, a "long road to recovery" as the company works to reestablish credibility. Schott keeps an Overweight rating on Valeant.

TODAY'S FREE FLY STORIES

SSNLF

Samsung

14:08
10/18/17
10/18
14:08
10/18/17
14:08
Periodicals
Samsung announces Bixby 2.0, Axios reports »

Samsung has announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 30

    Oct

SPX

S&P 500

14:03
10/18/17
10/18
14:03
10/18/17
14:03
Hot Stocks
Fed says economic activity increased in September through October »

The Federal Reserve says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYV

Live Nation

$42.77

1.355 (3.27%)

14:01
10/18/17
10/18
14:01
10/18/17
14:01
Recommendations
Live Nation analyst commentary  »

Live Nation deal with NFL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$14.46

0.52 (3.73%)

14:00
10/18/17
10/18
14:00
10/18/17
14:00
Options
Bullish option flow in Spectrum Pharm as shares surge »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

LYV

Live Nation

$42.75

1.34 (3.24%)

14:00
10/18/17
10/18
14:00
10/18/17
14:00
Periodicals
Ticketmaster, NFL extend ticketing relationship for five years, SBD says »

Live Nation's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEOS

Neos Therapeutics

$8.10

0.1 (1.25%)

13:52
10/18/17
10/18
13:52
10/18/17
13:52
Recommendations
Neos Therapeutics analyst commentary  »

Neos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$222.28

2.18 (0.99%)

13:52
10/18/17
10/18
13:52
10/18/17
13:52
Hot Stocks
FedEx long-term goals include increasing EPS 10%-15% per year »

Long-term financial goals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 09

    Nov

CAH

Cardinal Health

$65.46

0.38 (0.58%)

13:48
10/18/17
10/18
13:48
10/18/17
13:48
Hot Stocks
Cardinal Health moved lower after STAT story on California license »

Shares of Cardinal Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VIA

Viacom

$33.95

0.2 (0.59%)

, VIAB

Viacom

$26.57

0.31 (1.18%)

13:47
10/18/17
10/18
13:47
10/18/17
13:47
Periodicals
Viacom, Charter agree to network deal for basic package, Reuters reports »

Viacom (VIA, VIAB) and…

VIA

Viacom

$33.95

0.2 (0.59%)

VIAB

Viacom

$26.57

0.31 (1.18%)

CHTR

Charter

$357.84

-4.76 (-1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 16

    Nov

13:45
10/18/17
10/18
13:45
10/18/17
13:45
General news
Breaking General news story  »

September Beige Book to…

CAH

Cardinal Health

$65.50

0.415 (0.64%)

13:44
10/18/17
10/18
13:44
10/18/17
13:44
Periodicals
California wants to revoke Cardinal facility's wholesale license, STAT reports »

California wants to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

13:40
10/18/17
10/18
13:40
10/18/17
13:40
General news
Fed's Beige Book preview: »

Fed's Beige Book…

KEY

KeyCorp

$18.48

0.285 (1.57%)

13:37
10/18/17
10/18
13:37
10/18/17
13:37
Technical Analysis
Technical Earnings Preview: KeyCorp range-bound ahead of results »

The stock has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 02

    Nov

13:35
10/18/17
10/18
13:35
10/18/17
13:35
General news
NY Fed accepted $121.46 B in daily reverse repos »

NY Fed accepted $121.46 B…

OFC

Corporate Office Properties

$32.40

-0.155 (-0.48%)

13:17
10/18/17
10/18
13:17
10/18/17
13:17
Hot Stocks
Corporate Office says no shares issued following 1.1M share block trade »

Corporate Office…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 18

    Oct

$NSD

NASDAQ Market Internals

13:17
10/18/17
10/18
13:17
10/18/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
10/18/17
10/18
13:16
10/18/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNK

Cinemark

$35.25

-0.19 (-0.54%)

, JPM

JPMorgan

$98.41

0.79 (0.81%)

13:15
10/18/17
10/18
13:15
10/18/17
13:15
Hot Stocks
Cinemark now accepts Chase Pay online »

Cinemark Holdings (CNK)…

CNK

Cinemark

$35.25

-0.19 (-0.54%)

JPM

JPMorgan

$98.41

0.79 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 02

    Nov

  • 05

    Nov

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

CYH

Community Health

$6.28

-0.15 (-2.33%)

13:15
10/18/17
10/18
13:15
10/18/17
13:15
Options
Community Health put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 06

    Nov

VZ

Verizon

$48.08

-0.32 (-0.66%)

, T

AT&T

$35.71

-0.52 (-1.44%)

13:15
10/18/17
10/18
13:15
10/18/17
13:15
Earnings
On The Fly: What to watch in telecom sector earnings reports »

Verizon (VZ) is scheduled…

VZ

Verizon

$48.08

-0.32 (-0.66%)

T

AT&T

$35.71

-0.52 (-1.44%)

TMUS

T-Mobile

$60.94

-0.03 (-0.05%)

S

Sprint

$7.08

-0.01 (-0.14%)

SFTBF

SoftBank

$88.06

-1.745 (-1.94%)

DTEGY

Deutsche Telekom

$18.13

-0.14 (-0.77%)

GOOG

Alphabet

$992.18

0.18 (0.02%)

GOOGL

Alphabet Class A

$1,011.00

1.65 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 26

    Oct

  • 30

    Oct

  • 01

    Nov

  • 29

    Nov

  • 29

    Nov

  • 18

    Mar

  • 16

    May

13:10
10/18/17
10/18
13:10
10/18/17
13:10
General news
Treasury Action: the 5-year yield stalled out under 2.0% »

Treasury Action: the…

AZN

AstraZeneca

$34.64

-0.139 (-0.40%)

13:08
10/18/17
10/18
13:08
10/18/17
13:08
Hot Stocks
AstraZeneca: Data show greater boost in RSV hospitalization risk »

AstraZeneca announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 08

    Nov

  • 09

    Nov

PLT

Plantronics

$46.19

1.5 (3.36%)

13:05
10/18/17
10/18
13:05
10/18/17
13:05
Hot Stocks
GN Audio says jury ruled in favor of Plantronics »

GN Store Nord announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OFC

Corporate Office Properties

$32.43

-0.1162 (-0.36%)

13:05
10/18/17
10/18
13:05
10/18/17
13:05
Hot Stocks
Corporate Office Properties: News of stock offering 'incorrect' »

Corporate Office…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 18

    Oct

DISCA

Discovery

$19.16

0.1 (0.52%)

, SNAP

Snap

$15.81

-0.28 (-1.74%)

13:04
10/18/17
10/18
13:04
10/18/17
13:04
Hot Stocks
Discovery reaches content agreement with Snap in Europe for Olympic Games »

Discovery (DISCA)…

DISCA

Discovery

$19.16

0.1 (0.52%)

SNAP

Snap

$15.81

-0.28 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 02

    Nov

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.